MKS (NASDAQ:MKSI) Price Target Raised to $365.00 at JPMorgan Chase & Co.

Key Points

• JPMorgan raised its price target on MKS to $365 from $305 and kept an "overweight" rating, implying about a 15.7% upside$312.23.
• MKS beat Q1 estimates, reporting $2.30 EPS vs. $2.00 expected and $1.08B revenue vs. $1.05B, and set Q2 guidance of 2.600–3.200 EPS.
• The stock jumped about 4.9% to $315.44 on the news, though insiders sold roughly 68,503 shares (~$17.3M) over the last 90 days while institutional ownership remains extremely high at 99.79%.

MKS (NASDAQ:MKSI - Get Free Report) had its price objective boosted by investment analysts at JPMorgan Chase & Co. from $305.00 to $365.00 in a note issued to investors on Friday,Benzinga reports. The firm presently has an "overweight" rating on the scientific and technical instruments company's stock. JPMorgan Chase & Co.'s price target would indicate a potential upside of 15.71% from the stock's previous close.

A number of other equities analysts also recently weighed in on the stock. Bank of America boosted their target price on shares of MKS from $215.00 to $255.00 and gave the stock a "buy" rating in a report on Thursday, January 22nd. Deutsche Bank Aktiengesellschaft reissued a "buy" rating and issued a $380.00 price objective on shares of MKS in a research report on Friday. Needham & Company LLC boosted their price objective on shares of MKS from $300.00 to $360.00 and gave the stock a "buy" rating in a research note on Thursday. Mizuho set a $320.00 target price on shares of MKS in a report on Thursday, February 19th. Finally, KeyCorp raised their target price on shares of MKS from $310.00 to $360.00 and gave the company an "overweight" rating in a research note on Friday. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $312.23.

MKS Stock Up 4.9%

NASDAQ MKSI traded up $14.65 during trading hours on Friday, hitting $315.44. 1,201,834 shares of the company traded hands, compared to its average volume of 1,411,069. The company has a debt-to-equity ratio of 1.53, a quick ratio of 1.71 and a current ratio of 2.71. The business's 50-day moving average is $249.12 and its 200-day moving average is $205.60. The stock has a market capitalization of $21.24 billion, a price-to-earnings ratio of 66.11, a P/E/G ratio of 1.57 and a beta of 1.98. MKS has a twelve month low of $78.62 and a twelve month high of $326.83.

MKS (NASDAQ:MKSI - Get Free Report) last posted its quarterly earnings results on Wednesday, May 6th. The scientific and technical instruments company reported $2.30 earnings per share for the quarter, topping the consensus estimate of $2.00 by $0.30. MKS had a return on equity of 21.88% and a net margin of 8.06%.The firm had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. During the same quarter in the previous year, the firm earned $1.71 EPS. The business's quarterly revenue was up 15.2% on a year-over-year basis. MKS has set its Q2 2026 guidance at 2.600-3.200 EPS. Sell-side analysts anticipate that MKS will post 9.89 earnings per share for the current year.

Insider Transactions at MKS

In other MKS news, EVP Kathleen Flaherty Burke sold 4,254 shares of the firm's stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $250.00, for a total transaction of $1,063,500.00. Following the completion of the sale, the executive vice president directly owned 53,794 shares in the company, valued at $13,448,500. This trade represents a 7.33% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP John Edward Williams sold 2,043 shares of the business's stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $256.41, for a total value of $523,845.63. Following the sale, the executive vice president owned 3,640 shares of the company's stock, valued at approximately $933,332.40. This represents a 35.95% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 68,503 shares of company stock worth $17,288,099. 0.57% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the company. Blue Trust Inc. boosted its position in shares of MKS by 1.1% in the first quarter. Blue Trust Inc. now owns 4,274 shares of the scientific and technical instruments company's stock valued at $982,000 after acquiring an additional 47 shares during the period. Covestor Ltd increased its position in MKS by 14.7% during the fourth quarter. Covestor Ltd now owns 390 shares of the scientific and technical instruments company's stock worth $63,000 after acquiring an additional 50 shares during the period. Daiwa Securities Group Inc. raised its stake in MKS by 10.4% in the 4th quarter. Daiwa Securities Group Inc. now owns 530 shares of the scientific and technical instruments company's stock worth $85,000 after purchasing an additional 50 shares in the last quarter. Quadrant Capital Group LLC raised its stake in MKS by 1.3% in the 4th quarter. Quadrant Capital Group LLC now owns 4,335 shares of the scientific and technical instruments company's stock worth $693,000 after purchasing an additional 55 shares in the last quarter. Finally, MassMutual Private Wealth & Trust FSB boosted its holdings in MKS by 6.9% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 898 shares of the scientific and technical instruments company's stock valued at $144,000 after purchasing an additional 58 shares during the period. Institutional investors own 99.79% of the company's stock.

About MKS

MKS Instruments, Inc NASDAQ: MKSI designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company's core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company's product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.